Polymercaptan GH300 Cas:72244-98-5

We are Polymercaptan GH300 CAS:72244-98-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests





Polymercaptan GH300
72244-98-5
 
GPM800
Capcure3800
QE340-M
GABEPRO GPM-800 Mercaptan Polymer Curing Agent
gabriel mercaptan
capcure 3-800
capcure 3830-81
amine cured epoxy
amidoamine curing agent
huntsman epoxy curing agents
polyamide curing agent
Polymercaptan curing agent
Epoxy resin
mercaptan based epoxy hardener
epoxy curing agent
polymercaptan
amine hardener
 
Appearance: Clear liquid
SH: ≥12
Color: ≤30
Viscosity: 12000 – 15000 mPa·s
 
Product description
GH300 is an effective liquid curing agent for epoxy resins with light color and low toxicity. It has very fast curing speed at lower temperature and small film thickness, and can further improve the curing speed when used together with amine curing agent. Can replace GPM800/ Capcure3800/ QE340-M.
Can be used as epoxy resin curing agent/accelerator for quick-drying coatings, adhesives, casting, etc. It is especially suitable for use in the field of quick repair glue and low temperature curing in winter operations.
 
Features：
1. Fast curing at room temperature, with a variety of curing speed options;
2. Good transparency, low color;
3. Good heat resistance, water resistance and solvent resistance
 
Applications：
1. Industrial quick adhesive;
2. Building structural adhesive;
3. Epoxy potting, lamination, casting;
4. Epoxy curing accelerator
 
Storage and packaging
220L/drum or 1000L IBC drum
This product should be stored in a cool, ventilated and dry place.
 
This product is transported as a non-hazardous chemical.

Market News:The booster campaign, with shots administered by health maintenance organisations, will effectively turn Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration (FDA). Heptanoic acid, 3-hydroxy-2,2,3-trimethyl-4-oxo-, dodecyl ester manufacturer.The factory is part of a partnership with Nichepharm Lifesciences of India. Recipharm has an 8% stake in that company after an investment two years ago. (4-tert-Butyl-[1,3,2]dioxaphospholan-2-yl)-diethyl-amine supplier.EMA said it considered that the results of the clinical studies used to support the application “were inconsistent and did not satisfactorily show that Nouryant was effective at reducing the ‘off’ time. 1-(4-bromo-2-fluoro-5-(methoxymethoxy)phenyl)-4-(3-fluoropropyl)-1,4-dihydro-5H-tetrazol-5-one producer.